Parabilis Medicines, Inc. · NASDAQ:PBLS
Parabilis Medicines, Inc. shareholders
As of Jun 30, 2026, 76 institutions reported holding Parabilis Medicines, Inc., 80.1% of its shares. Largest: Ra Capital Management, L.P., Fidelity and ARCH Venture Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Parabilis Medicines, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 28.9M | 23.4% | new | Aug 14, 2026 |
| Fidelity | 10.3M | 8.3% | new | Aug 13, 2026 |
| ARCH Venture Management, LLC | 6.41M | 5.2% | new | Aug 14, 2026 |
| venBio Partners LLC | 5.27M | 4.3% | new | Aug 14, 2026 |
| Alphabet Inc. | 4.92M | 4.0% | new | Aug 7, 2026 |
| Nextech Invest Ltd. | 4.66M | 3.8% | new | Aug 14, 2026 |
| Cormorant Asset Management, LP | 4.62M | 3.7% | new | Aug 14, 2026 |
| Regeneron Pharmaceuticals, Inc. | 4.17M | 3.4% | new | Aug 7, 2026 |
| Siren, L.L.C. | 2.99M | 2.4% | new | Aug 13, 2026 |
| Vanguard | 2.5M | 2.0% | new | Aug 13, 2026 |